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Abstract
Background: Extended-spectrum β-lactamase-producing Escherichia coli has become ubiquitous and has been
reported in diverse ecosystems. We evaluated the potential impact of post-acute and long-term healthcare activities
on the environment by quantifying ESBL-producing Enterobacteriaceae in wastewaters of a French geriatric
hospital.
Methods: We collected wastewater specimens representative of one-day efflux immediately before the connection
with the municipal sewer pipe. The sample was processed following two different methods: dilution-filtration
method and concentration method and was screened for ESBL-producing Enterobacteriaceae using selective
media. ESBL E. coli strains were quantified, screened for ESBL genes and compared with ESBL strains isolated from
patients present in the building at the time of wastewater collection, using molecular methods.
Results: Six distinct environmental ESBL E. coli clusters were identified, two of them related to patient strains. The
concentrations in hospital wastewater of these strains ranged from 2.5 × 104 to 106 UFC/L.
Conclusions: Our results demonstrate that the presence of ESBL E. coli patients leads to a dissemination of ESBL
E. coli in the environment and highlights the need to improve excreta and wastewater policy in hospitals.
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Background
The first extended-spectrum β-lactamases (ESBLs) were
isolated in the 1980’s [1, 2]. Since the early 2000’s, CTX-
M-type ESBLs have spread worldwide among Escherichia
coli strains in hospitals and in the community [3, 4].
ESBL-producing E. coli have been reported in diverse hu-
man communities, even in remote populations [5], pets
[6, 7], farm animals [8–10], lakes and river [11], wildlife
[12] and soils [10]. Presence of ESBL-producing E. coli
has been demonstrated in hospital wastewater [13–17]
however the link between the presence of ESBL-
producing E. coli in hospital wastewater and patients
infected or colonized with such bacteria remains un-
clear. In this study, we focused on a building of our
hospital and quantified ESBL-producing Enterobacteri-
aceae in wastewaters discharged from this building.
Methods
Hospital setting
The study was conducted at the Charles Foix hospital, a
450-bed teaching medical institution located at Ivry-sur-
Seine, suburb of Paris, France. We focused the study on
the building Calmette et Guérin (CG, 126 beds) which is
constituted of geriatric post-acute care (PAC), long-term
care (LTC) units along with a little psychiatric unit.
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Wastewater collection
From December 29th 2010 9.30 am until December 30th
2010 9.30 am, wastewater samples were collected at the
sewer pipe that collects wastewaters from the CG build-
ing, immediately before the connection with the munici-
pal sewer pipe. At this collection point, 140-mL samples
were collected every 15 min within 24 h using an
automatic refrigerated water sampler (Teledyne Isco,
Lincoln, NE, USA). These samples were mixed to
constitute a specimen representative of one-day efflux.
Flow, pH and temperature were continuously monitored.
Wastewater processing
The sample was processed on the same day following
two methods, i.e. the dilution-filtration method and the
concentration method.
In the dilution-filtration method, the sample was di-
luted in sterile saline solution (10-2–7) and 2 volumes of
100 mL of each diluted suspensions were filtrated on
0.45 μm nitrocellulose membranes (Merck Millipore,
Billerica, MA, USA). These membranes were deposited
on two distinct selective agars: chromID® ESBL agar
(bioMérieux, Marcy l’Etoile, France) and Drigalski agar
supplemented with cefotaxime (0.5 mg/L) and ticarcillin
(250 mg/L) (Drig-TC).
In the concentration method, 20 mL of the wastewater
specimen were filtrated on a 0.4 μm polycarbonate Iso-
pore® membrane (Merck Millipore, Billerica, MA, USA)
and then suspended in 5 mL sterile saline solution using
a sterile cell scraper. These suspensions were then
diluted in sterile saline solution (10-1–6) and 100 μL of
each diluted suspension were plated on both chromID®
ESBL and Drig-TC agars.
Patients
The microbiological database was screened for patients
present in the building at the time of wastewater collec-
tion and whose bacteriological specimens, taken either
for clinical or bacteriological (i.e. rectal swab) were posi-
tive for ESBL-producing E. coli.
Bacterial strains and susceptibility assays
Environmental, epidemiological and clinical strains were
identified by API 20E® system (bioMérieux, Marcy
l’Etoile, France). Susceptibility to antimicrobial agents
was assessed by disk diffusion method according to
French guidelines (www.sfm-microbiologie.org) and
ESBL production was screened by the double disk syn-
ergy test (DDST) [18].
Beta-lactamase characterization and screening of
resistance genes
Each strain displaying a positive DDST was screened for
the presence of for the blaTEM, blaSHV and blaCTX-M
genes, using PCR amplification and sequencing as re-
ported before [19].
Molecular typing
Wastewater and patient ESBL-producing strains of
E. coli were compared using the semi-automated
typing system DiversiLab® (bioMérieux, Marcy l’Etoile,
France) as described elsewhere [20] using 95 % similarity
threshold to consider fingerprints as similar.
When DiversiLab fingerprints were considered as
similar, the corresponding strains were further studied
by Pulsed-Field Gel Electrophoresis (PFGE) as reported
before [21].
Results
At collection point, the flow was 39,270 m3 per day, the
temperature ranged from 12 to 17.3 °C and the pH
ranged from 6.2 to 8.9.
Each distinct colony that grew on selective agar plates
(chromID® ESBL and Drig-TC) inoculated with wastewa-
ter processed by dilution-filtration or concentration
method was identified and screened for ESBL produc-
tion. A total of 389 colonies could be individualized and
were studied. Most of them were non fermentative
bacteria or cephalosporinase-producing enterobacteria.
Twenty-five colonies were identified as ESBL-producing
Enterobacteriaceae, including 23 E. coli and two Entero-
bacter cloacae. The concentrations of ESBL-producing
E. coli in wastewater was estimated using the number of
colonies, the dilution factor and the volume filtrated.
This estimated concentrations ranged between 1 × 106
UFC/L based on the characteristics of the dilution-
filtration method, and 2.5 × 105 UFC/L based on the
characteristics of the concentration method.
Nine patients hospitalized in the CG building at the
time of wastewater collection had been identified carry-
ing ESBL E. coli. The 23 isolates from wastewater and 9
strains isolated from 9 carriers were submitted to geno-
typing and identification of ESBL-encoding genes.
The 23 wastewater ESBL E. coli isolates belonged to 5
distinct DiversiLab® patterns: 14 to pattern 1, four to
pattern 2, two to patterns 3 and 5, respectively, and one
to pattern 4 (Table 1). The isolates belonging to the
DiversiLab® profile 1 was subdivided into two pulsotypes
1a and 1b. PFGE 1a corresponded to isolates carrying the
ESBL blaCTXM-14 and the broad-spectrum β-lactamase
blaTEM-1 genes. PFGE 1b corresponded to ESBL CTX-M-
27-producing isolates (Table 1). Other clusters produced
CTX-M-1 or TEM-3.
Thus, a total of six distinct clusters of ESBL-producing
E. coli clusters (WWCG1a to WWCG5) were identified
in wastewater. The concentrations of each cluster was
estimated using the number of colonies belonging to this
cluster, the dilution factor and the volume filtrated. The
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estimated concentration ranged from 2.5 × 104 to 106
UFC/L (Table 1). Most of them (4/6) produced a
CTX-M-type ESBL, the others producing TEM-3.
The genotyping results obtained for the 9 ESBL-
producing E. coli strains from patients, showed that five
of them were undistinguishable (Table 2). These five
strains were also undistinguishable from the wastewater
WWCG1b cluster defined above and carried the blaCTX-
M-27 gene. These strains had been isolated from three
patients hospitalized in the same post-acute care ward
(PAC-Mong) (Table 2), from one patient hospitalized in
the long-term care ward but who had been previously
hospitalized in PAC-Mong unit at the same time as the
above patients, and from one patient hospitalized in a
distinct post-acute care ward (PAC-Nec) that shares
nursing and medical staffs with PAC-Mong ward. One
patient strain cluster belonged to DiversiLab® profile 1
and pulsotype 1a, carried blaCTXM-14 and blaTEM-1 genes
and consequently was undistinguishable from wastewa-
ter cluster WWCG1a (Table 2).
The other three patients strains were distinct one from
each other and also distinct from wastewater isolates.
Discussion
Enterobacteriaceae, particularly E. coli, are commensal
bacteria present at about 108 colony-forming units per
gram of human faeces. The faecal concentration of
ESBL-producing E. coli may vary with the antibiotic
treatment and it has been shown that the mean relative
faecal abundance of ESBL-producing E. coli was 13-fold
higher in women exposed to antimicrobials [22]. Even
before ESBLs were first reported, hospitals were consid-
ered as sources of environmental pollution with multire-
sistant E. coli strains. Indeed, in 1973, Grabow et al.
reported that the proportion of E. coli carrying multire-
sistant conjugative plasmids was higher (26 % vs 4 %) in
hospital wastewater samples than in city sewage samples
[23]. As hospital settings concentrate ESBL-producing E.
coli carriers, they can be a source of environmental
ESBL-type pollution.
Several studies have focused on hospital discharge of
ESBL-producing Enterobacteriaceae [13–17]. However,
in most cases, sewages were sampled by filling directly
sterile bottles, i.e. by studying random specimens of
wastewater. In our study, the sewage point was sampled
using equipment allowing the collection of a specimen
representative of a daily wastewater discharge, taking
into account quantitative and qualitative variations of
flow that can be observed within a single day.
Moreover, in most of the above studies, Enterobac-
teriaceae were enumerated but the presence of ESBL-
producing strains was notified without the range
quantification [13–16]. In our study, we estimated the
concentration of ESBL-producing E. coli based on the
Table 1 Characteristics of the ESBL-producing Escherichia coli clusters isolated from wastewater specimen
Cluster Range of enumeration in wastewater (UFC/L) a β-lactamases DiversiLab® pattern Pulsotype
WWCG1a 2 × 104 – 4 × 104 a CTX-M-14, TEM-1 1 1a
WWCG1b 2.5 × 104 – 2.5 × 105 a CTX-M-27 1 1b
WWCG2 1 × 104 - 1 × 106 a CTX-M-1 2 -
WWCG3 2 × 104 TEM-3 3 -
WWCG4 1 × 104 TEM-3 4 -
WWCG5 2 × 104 CTX-M-1, TEM-1 5 -
aConcentration estimated for both the dilution-filtration method and the concentration method
Table 2 Characteristics of the ESBL-producing Escherichia coli strains isolated from patients present at the time of wastewater
collection
Patient Unit of hospitalizationa Specimen β-lactamases DiversiLab® type Pulsotype Corresponding wastewater clusterb
1 PAC-Nec. Rectal swab CTX-M-27 1 1b WWCG1b
2 PAC-Mong. Rectal swab CTX-M-27 1 1b WWCG1b
3 PAC-Mong. Rectal swab CTX-M-27 1 1b WWCG1b
4 PAC-Mong. Rectal swab, urine CTX-M-27 1 1b WWCG1b
5 LTC wound CTX-M-27 1 1b WWCG1b
6 PAC-UPG Urine CTX-M-14, TEM-1 1 1a WWCG1a
7 PAC-Mong. Rectal swab CTX-M-15, TEM-1 1 1c -
8 LTC Rectal swab CTX-M-1, TEM-1 6 - -
9 PAC-Mong. Rectal swab CTX-M-15, TEM-30 7 - -
aunit of hospitalization at the time of wastewater collection; PAC post-acute care wards, LTC long-term care ward; bsee Table 1 for definition
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specimen processing. Concentrations we have found
are consistent with the concentration of cefotaxime-
resistant E. coli strains reported by Galvin et al. in
the effluents of an Irish hospital (estimation, 105
UFC/L) [15]. Most of the environmental ESBL E. coli
isolates (20/23) found in our hospital wastewater
produced a CTX-M-type ESBL belonging either to
group 1 or to group 9 and few to TEM type. This
predominance of CTX-M-type ESBLs is consistent
with the relative distribution of ESBL enzymes among
clinical ESBL E. coli in France [24].
Molecular typing of wastewater ESBL isolates allowed
identifying and quantifying two clusters carried by pa-
tients present in the building at the time of wastewater
collection.
To our knowledge, the present study is the first report
of ESBL-producing E. coli quantification in sewage in
direct relation with strains isolated from patients.
Conclusions
The present study demonstrates that the presence of
ESBL-producing E. coli carriers in hospital may lead to a
dissemination of ESBL-producing E. coli in the environ-
ment, with a quantification of ESBL-producing E. coli in
sewage in direct relation with strains isolated from
patients. In this matter, Healthcare settings play an im-
portant role in ESBL-producing bacteria spread, not only
through cross-transmission and antibiotics consumption,
but also through their wastes and should improve their
disposal of human excreta in order to reduce their im-
pact on the environment.
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